1Miyakis S, Lockshin MD’Atsumi T,et al.Internationalconsensus statement on an update of the classificationcriteria for definite antiphespholipid syndrome [ J] .JThromb Haemost,2006,4 (2) :295-306.
4ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin: antiphospholipid syndrome [ J ]. Obstet Gynecol, 2005,106 ( 5 pt 1 ) : 1113 -1121.
5Wassermann A, Neisser A, Bruck C. Eine serodiagnostische reaction bei syphilis [ J ]. Dtsch Med Wochenschr, 1906,32:745 -746.
6Long AA, Ginsberg JS, Brin-Edwards P, et al. The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus ervthematosus a cross-sectional study[ J]. Thromb Haemost,1991,66(5) :520-524.
7Vila P, Hernandez MC, Lopez-Femandez MF, et al. Prevalence,follow-up and clinical significance of the anticardiolipin antibodies in normal subjects [ J ]. Thromb Haemost, 1994,72 ( 2 ) : 209-213.
9Mateo J, Oliver A, Borrell M, et al. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism: results of the Spanish Muhicentric Study on Thrombophilia (EMET-Study) [ J ]. Thromb Haemost, 1997,77 ( 3 ) :444-451.
10Gaili M, Lueiani D,Bertolini G,et al. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiollpin antibodies in the antiphospbolipid syndrome:a systematic review of the literature [ J ]. Blood, 2003,101 ( 5 ) : 1827- 1832.
